Colleen Julian
Concepts (382)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Altitude | 54 | 2024 | 451 | 9.740 |
Why?
| Pre-Eclampsia | 14 | 2024 | 183 | 4.180 |
Why?
| Fetal Growth Retardation | 23 | 2024 | 542 | 3.990 |
Why?
| Uterine Artery | 15 | 2024 | 74 | 3.150 |
Why?
| Hypoxia | 27 | 2024 | 1070 | 3.110 |
Why?
| Placenta | 10 | 2023 | 706 | 2.910 |
Why?
| Fetal Hypoxia | 8 | 2024 | 51 | 2.660 |
Why?
| Altitude Sickness | 15 | 2022 | 138 | 2.470 |
Why?
| Pregnancy | 59 | 2024 | 6247 | 2.350 |
Why?
| Adaptation, Physiological | 12 | 2021 | 516 | 2.020 |
Why?
| AMP-Activated Protein Kinases | 7 | 2024 | 187 | 1.920 |
Why?
| Acclimatization | 13 | 2019 | 161 | 1.880 |
Why?
| PPAR gamma | 3 | 2020 | 182 | 1.600 |
Why?
| Birth Weight | 13 | 2024 | 493 | 1.540 |
Why?
| Placental Circulation | 7 | 2024 | 63 | 1.520 |
Why?
| Oxygen | 16 | 2023 | 912 | 1.470 |
Why?
| Fetal Development | 8 | 2024 | 283 | 1.430 |
Why?
| Bolivia | 17 | 2024 | 63 | 1.210 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2022 | 70 | 1.010 |
Why?
| Pregnancy Outcome | 4 | 2019 | 379 | 1.000 |
Why?
| Selection, Genetic | 7 | 2019 | 250 | 1.000 |
Why?
| Hypertension, Pregnancy-Induced | 5 | 2023 | 67 | 0.980 |
Why?
| Pregnancy Complications | 5 | 2017 | 487 | 0.960 |
Why?
| Hemodynamics | 4 | 2024 | 1095 | 0.930 |
Why?
| Endothelin-1 | 2 | 2020 | 179 | 0.860 |
Why?
| Female | 73 | 2024 | 68162 | 0.800 |
Why?
| Biology | 1 | 2023 | 82 | 0.800 |
Why?
| Uterus | 4 | 2020 | 204 | 0.780 |
Why?
| Gestational Age | 12 | 2024 | 857 | 0.690 |
Why?
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 114 | 0.690 |
Why?
| Sympathetic Nervous System | 6 | 2020 | 184 | 0.670 |
Why?
| Regional Blood Flow | 8 | 2024 | 462 | 0.670 |
Why?
| Hypertension, Pulmonary | 2 | 2022 | 1876 | 0.670 |
Why?
| Infant, Newborn | 15 | 2024 | 5704 | 0.650 |
Why?
| Neovascularization, Physiologic | 1 | 2021 | 179 | 0.650 |
Why?
| Polycythemia | 3 | 2017 | 22 | 0.630 |
Why?
| Adult | 46 | 2024 | 35361 | 0.610 |
Why?
| Erythropoietin | 3 | 2017 | 89 | 0.590 |
Why?
| Humans | 79 | 2024 | 128896 | 0.590 |
Why?
| Pulmonary Circulation | 2 | 2021 | 429 | 0.570 |
Why?
| Vascular Diseases | 2 | 2017 | 241 | 0.550 |
Why?
| Receptors, Erythropoietin | 1 | 2017 | 23 | 0.540 |
Why?
| Epigenesis, Genetic | 3 | 2023 | 613 | 0.530 |
Why?
| Infant, Small for Gestational Age | 3 | 2011 | 83 | 0.500 |
Why?
| Case-Control Studies | 9 | 2024 | 3334 | 0.500 |
Why?
| Gene Expression Regulation | 3 | 2021 | 2520 | 0.490 |
Why?
| Vascular Endothelial Growth Factor A | 3 | 2023 | 528 | 0.490 |
Why?
| Enzymes | 2 | 2013 | 65 | 0.480 |
Why?
| Arteries | 3 | 2022 | 268 | 0.470 |
Why?
| Signal Transduction | 4 | 2024 | 4857 | 0.450 |
Why?
| Vasodilation | 4 | 2022 | 480 | 0.450 |
Why?
| Young Adult | 20 | 2024 | 12286 | 0.450 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 2021 | 544 | 0.430 |
Why?
| Sleep Apnea Syndromes | 1 | 2013 | 78 | 0.390 |
Why?
| DNA Methylation | 2 | 2023 | 600 | 0.390 |
Why?
| Blood Proteins | 1 | 2013 | 233 | 0.380 |
Why?
| Antioxidants | 2 | 2013 | 557 | 0.380 |
Why?
| Vascular Resistance | 5 | 2024 | 373 | 0.370 |
Why?
| Hemoglobins | 7 | 2017 | 343 | 0.370 |
Why?
| Infant, Low Birth Weight | 2 | 2011 | 134 | 0.370 |
Why?
| Middle Cerebral Artery | 3 | 2024 | 45 | 0.370 |
Why?
| Oxygen Consumption | 2 | 2011 | 676 | 0.370 |
Why?
| Cell Membrane Permeability | 1 | 2011 | 82 | 0.360 |
Why?
| Erythrocytes | 4 | 2017 | 667 | 0.360 |
Why?
| Biological Evolution | 2 | 2015 | 426 | 0.340 |
Why?
| Placental Insufficiency | 2 | 2023 | 111 | 0.340 |
Why?
| Erythropoiesis | 2 | 2014 | 50 | 0.330 |
Why?
| Oxidative Stress | 2 | 2013 | 1220 | 0.330 |
Why?
| Cerebrovascular Circulation | 4 | 2024 | 223 | 0.320 |
Why?
| Polymorphism, Single Nucleotide | 8 | 2019 | 2070 | 0.320 |
Why?
| Lung Diseases | 1 | 2015 | 755 | 0.310 |
Why?
| Fertility | 1 | 2009 | 161 | 0.300 |
Why?
| Women's Health | 1 | 2011 | 361 | 0.300 |
Why?
| Lung | 1 | 2021 | 3925 | 0.290 |
Why?
| Proteomics | 1 | 2013 | 985 | 0.280 |
Why?
| Receptor, Adenosine A2B | 2 | 2017 | 32 | 0.270 |
Why?
| Hypertension | 1 | 2015 | 1236 | 0.270 |
Why?
| Maternal-Fetal Exchange | 2 | 2021 | 159 | 0.260 |
Why?
| Disease Models, Animal | 3 | 2021 | 3994 | 0.250 |
Why?
| Animals | 13 | 2024 | 34628 | 0.240 |
Why?
| Nitric Oxide | 2 | 2020 | 892 | 0.240 |
Why?
| Cardiovascular Physiological Phenomena | 1 | 2024 | 44 | 0.220 |
Why?
| Placenta Growth Factor | 2 | 2022 | 23 | 0.220 |
Why?
| HELLP Syndrome | 1 | 2023 | 6 | 0.220 |
Why?
| Physical Education and Training | 1 | 2003 | 76 | 0.220 |
Why?
| Blood Pressure | 7 | 2020 | 1743 | 0.220 |
Why?
| Mice, Inbred C57BL | 5 | 2021 | 5270 | 0.210 |
Why?
| Phenylephrine | 2 | 2020 | 75 | 0.210 |
Why?
| Ion Channels | 1 | 2023 | 126 | 0.210 |
Why?
| Amino Acids | 3 | 2023 | 469 | 0.210 |
Why?
| Muscle, Skeletal | 5 | 2023 | 1629 | 0.210 |
Why?
| Mice | 7 | 2021 | 16543 | 0.200 |
Why?
| Task Performance and Analysis | 1 | 2003 | 174 | 0.200 |
Why?
| Baroreflex | 3 | 2020 | 61 | 0.200 |
Why?
| Geography | 3 | 2011 | 185 | 0.200 |
Why?
| Phenotype | 2 | 2023 | 3059 | 0.200 |
Why?
| Longitudinal Studies | 3 | 2019 | 2668 | 0.200 |
Why?
| Vascular Endothelial Growth Factors | 1 | 2022 | 76 | 0.200 |
Why?
| Male | 19 | 2019 | 63146 | 0.200 |
Why?
| Cesarean Section | 1 | 2023 | 180 | 0.190 |
Why?
| Arterial Pressure | 3 | 2020 | 118 | 0.190 |
Why?
| Acute Disease | 3 | 2013 | 978 | 0.190 |
Why?
| Acetazolamide | 2 | 2011 | 24 | 0.190 |
Why?
| Abortion, Spontaneous | 2 | 2020 | 97 | 0.180 |
Why?
| Postpartum Period | 1 | 2024 | 332 | 0.180 |
Why?
| Running | 1 | 2003 | 229 | 0.180 |
Why?
| Cross-Sectional Studies | 4 | 2022 | 5032 | 0.180 |
Why?
| Ventricular Pressure | 1 | 2021 | 44 | 0.180 |
Why?
| Pedigree | 2 | 2020 | 491 | 0.180 |
Why?
| Phosphorylation | 3 | 2021 | 1685 | 0.180 |
Why?
| Biomarkers | 4 | 2017 | 3874 | 0.180 |
Why?
| Frailty | 1 | 2023 | 148 | 0.180 |
Why?
| Cardiovascular System | 2 | 2024 | 138 | 0.180 |
Why?
| Hyperbaric Oxygenation | 1 | 2021 | 40 | 0.180 |
Why?
| Mammals | 1 | 2022 | 267 | 0.180 |
Why?
| Blood Volume | 3 | 2017 | 60 | 0.170 |
Why?
| Inflammation | 1 | 2011 | 2694 | 0.170 |
Why?
| Europe | 4 | 2009 | 366 | 0.170 |
Why?
| Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 14 | 0.170 |
Why?
| Genomics | 2 | 2023 | 715 | 0.170 |
Why?
| Myometrium | 1 | 2020 | 35 | 0.170 |
Why?
| Geographic Mapping | 1 | 2019 | 20 | 0.170 |
Why?
| Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2017 | 21 | 0.160 |
Why?
| Pulmonary Artery | 2 | 2015 | 1091 | 0.160 |
Why?
| Thiazolidinediones | 1 | 2020 | 136 | 0.160 |
Why?
| Dexamethasone | 2 | 2011 | 330 | 0.160 |
Why?
| Genetics, Population | 2 | 2010 | 200 | 0.150 |
Why?
| Ventricular Function, Right | 1 | 2021 | 274 | 0.150 |
Why?
| Nitric Oxide Synthase | 1 | 2019 | 238 | 0.150 |
Why?
| Adenosine | 2 | 2017 | 213 | 0.150 |
Why?
| Protein Kinases | 1 | 2020 | 305 | 0.150 |
Why?
| Gene Expression | 1 | 2023 | 1476 | 0.150 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 395 | 0.150 |
Why?
| Peroneal Nerve | 1 | 2017 | 19 | 0.150 |
Why?
| Fetus | 3 | 2023 | 764 | 0.140 |
Why?
| Trophoblasts | 1 | 2019 | 186 | 0.140 |
Why?
| Maternal Health Services | 1 | 2019 | 93 | 0.140 |
Why?
| Time Factors | 5 | 2017 | 6568 | 0.140 |
Why?
| Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 13 | 0.140 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 245 | 0.140 |
Why?
| Cell Cycle Proteins | 1 | 2021 | 576 | 0.140 |
Why?
| Epigenomics | 1 | 2017 | 111 | 0.140 |
Why?
| Muscle, Smooth, Vascular | 1 | 2019 | 430 | 0.130 |
Why?
| Heart Rate | 5 | 2020 | 807 | 0.130 |
Why?
| Colorado | 3 | 2019 | 4443 | 0.130 |
Why?
| Sphingosine | 1 | 2016 | 39 | 0.130 |
Why?
| Lysophospholipids | 1 | 2016 | 71 | 0.130 |
Why?
| Autonomic Pathways | 1 | 2015 | 2 | 0.130 |
Why?
| Immunohistochemistry | 1 | 2020 | 1694 | 0.120 |
Why?
| California | 1 | 2017 | 402 | 0.120 |
Why?
| Double-Blind Method | 3 | 2011 | 1858 | 0.120 |
Why?
| Pregnancy Complications, Cardiovascular | 2 | 2024 | 79 | 0.120 |
Why?
| Pulmonary Gas Exchange | 1 | 2015 | 119 | 0.120 |
Why?
| Pulmonary Veins | 1 | 2015 | 95 | 0.120 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 822 | 0.110 |
Why?
| Receptor, Endothelin A | 1 | 2014 | 62 | 0.110 |
Why?
| Muscles | 1 | 2015 | 322 | 0.110 |
Why?
| Ultrasonography, Prenatal | 4 | 2024 | 266 | 0.110 |
Why?
| Diabetes, Gestational | 1 | 2018 | 306 | 0.110 |
Why?
| Aromatase | 1 | 2014 | 31 | 0.110 |
Why?
| Biological Transport | 2 | 2019 | 394 | 0.110 |
Why?
| Parity | 3 | 2018 | 120 | 0.110 |
Why?
| Homeostasis | 2 | 2014 | 604 | 0.110 |
Why?
| Incidence | 2 | 2018 | 2634 | 0.110 |
Why?
| Tibet | 4 | 2017 | 27 | 0.110 |
Why?
| Prospective Studies | 3 | 2022 | 7060 | 0.110 |
Why?
| Congenital Abnormalities | 2 | 1991 | 74 | 0.100 |
Why?
| Ultrasonography, Doppler | 3 | 2020 | 118 | 0.100 |
Why?
| Leukocytes, Mononuclear | 1 | 2015 | 543 | 0.100 |
Why?
| Delivery, Obstetric | 2 | 2011 | 133 | 0.100 |
Why?
| Body Height | 1 | 2013 | 191 | 0.100 |
Why?
| Endothelium, Vascular | 1 | 2019 | 917 | 0.100 |
Why?
| Glycolysis | 3 | 2021 | 295 | 0.100 |
Why?
| Regression Analysis | 3 | 2018 | 987 | 0.100 |
Why?
| Polysomnography | 1 | 2013 | 155 | 0.100 |
Why?
| Healthy Volunteers | 3 | 2017 | 204 | 0.100 |
Why?
| Prenatal Diagnosis | 2 | 1991 | 189 | 0.100 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2013 | 484 | 0.100 |
Why?
| Health Services Accessibility | 1 | 2019 | 894 | 0.100 |
Why?
| Risk Factors | 6 | 2019 | 9792 | 0.090 |
Why?
| Carbonic Anhydrase Inhibitors | 1 | 2011 | 14 | 0.090 |
Why?
| Apgar Score | 1 | 2011 | 18 | 0.090 |
Why?
| Hypoxia, Brain | 1 | 2011 | 8 | 0.090 |
Why?
| Mountaineering | 1 | 2011 | 34 | 0.090 |
Why?
| Tandem Mass Spectrometry | 1 | 2013 | 441 | 0.090 |
Why?
| Estrogens | 1 | 2014 | 348 | 0.090 |
Why?
| Respiratory Physiological Phenomena | 1 | 2011 | 30 | 0.090 |
Why?
| Brain Edema | 1 | 2011 | 61 | 0.090 |
Why?
| Respiratory Function Tests | 1 | 2013 | 596 | 0.090 |
Why?
| Angiostatic Proteins | 1 | 2010 | 5 | 0.090 |
Why?
| Lactic Acid | 2 | 2023 | 296 | 0.090 |
Why?
| Angiogenic Proteins | 1 | 2010 | 16 | 0.090 |
Why?
| Follow-Up Studies | 2 | 2017 | 4917 | 0.090 |
Why?
| Confidence Intervals | 1 | 2011 | 318 | 0.090 |
Why?
| Headache | 1 | 2011 | 138 | 0.090 |
Why?
| Blood-Brain Barrier | 1 | 2011 | 128 | 0.090 |
Why?
| Oxidation-Reduction | 1 | 2013 | 1013 | 0.080 |
Why?
| Retrospective Studies | 4 | 2022 | 14546 | 0.080 |
Why?
| Anthropology, Physical | 1 | 2009 | 28 | 0.080 |
Why?
| Fetal Diseases | 1 | 1991 | 148 | 0.080 |
Why?
| Sheep | 2 | 2023 | 832 | 0.080 |
Why?
| Databases, Genetic | 1 | 2010 | 226 | 0.080 |
Why?
| Cohort Studies | 3 | 2020 | 5394 | 0.080 |
Why?
| HIV Infections | 1 | 2023 | 2696 | 0.080 |
Why?
| Fetal Blood | 1 | 2011 | 315 | 0.080 |
Why?
| Up-Regulation | 1 | 2011 | 848 | 0.080 |
Why?
| South America | 3 | 2014 | 56 | 0.080 |
Why?
| Prognosis | 1 | 2017 | 3787 | 0.080 |
Why?
| Interleukin-1beta | 1 | 2010 | 376 | 0.070 |
Why?
| Genome, Human | 1 | 2010 | 393 | 0.070 |
Why?
| Anti-Inflammatory Agents | 1 | 2011 | 468 | 0.070 |
Why?
| Chronic Disease | 1 | 2013 | 1715 | 0.070 |
Why?
| Head | 1 | 2008 | 96 | 0.070 |
Why?
| Adolescent | 3 | 2019 | 20197 | 0.070 |
Why?
| Urban Health | 1 | 2007 | 77 | 0.070 |
Why?
| Rest | 2 | 2019 | 121 | 0.070 |
Why?
| 5'-Nucleotidase | 2 | 2017 | 37 | 0.070 |
Why?
| 2,3-Diphosphoglycerate | 2 | 2016 | 32 | 0.070 |
Why?
| Health Status | 1 | 2011 | 750 | 0.070 |
Why?
| GPI-Linked Proteins | 2 | 2017 | 67 | 0.070 |
Why?
| Indians, South American | 3 | 2013 | 22 | 0.070 |
Why?
| Femur | 1 | 2008 | 242 | 0.070 |
Why?
| Blood Flow Velocity | 3 | 2013 | 413 | 0.060 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2007 | 105 | 0.060 |
Why?
| Haplotypes | 2 | 2017 | 473 | 0.060 |
Why?
| Cold Temperature | 2 | 2017 | 150 | 0.060 |
Why?
| Maternal Age | 2 | 2018 | 121 | 0.060 |
Why?
| Mental Health | 1 | 2011 | 675 | 0.060 |
Why?
| Down Syndrome | 1 | 1991 | 454 | 0.060 |
Why?
| Umbilical Arteries | 1 | 2024 | 49 | 0.060 |
Why?
| Reticulocyte Count | 1 | 2003 | 6 | 0.060 |
Why?
| Receptors, Transferrin | 1 | 2003 | 23 | 0.060 |
Why?
| Chi-Square Distribution | 2 | 2018 | 513 | 0.060 |
Why?
| Indians, North American | 1 | 2009 | 603 | 0.050 |
Why?
| Age Factors | 1 | 2011 | 3133 | 0.050 |
Why?
| Gene Expression Profiling | 1 | 2010 | 1694 | 0.050 |
Why?
| Pyruvates | 1 | 2023 | 23 | 0.050 |
Why?
| Solubility | 1 | 2003 | 233 | 0.050 |
Why?
| Surveys and Questionnaires | 3 | 2013 | 5355 | 0.050 |
Why?
| Glutamine | 1 | 2023 | 94 | 0.050 |
Why?
| Body Weight | 1 | 2007 | 931 | 0.050 |
Why?
| Serine | 1 | 2023 | 133 | 0.050 |
Why?
| Cytokines | 1 | 2010 | 1995 | 0.050 |
Why?
| Glycine | 1 | 2023 | 162 | 0.050 |
Why?
| Potassium Channels | 1 | 2022 | 139 | 0.050 |
Why?
| Developing Countries | 1 | 2023 | 278 | 0.050 |
Why?
| Gene Frequency | 2 | 2014 | 503 | 0.050 |
Why?
| Pyruvic Acid | 1 | 2021 | 52 | 0.050 |
Why?
| Blood Gas Analysis | 2 | 2014 | 71 | 0.050 |
Why?
| Amniocentesis | 2 | 1991 | 23 | 0.040 |
Why?
| Pregnancy Trimester, Third | 2 | 2019 | 105 | 0.040 |
Why?
| Aminoimidazole Carboxamide | 1 | 2020 | 11 | 0.040 |
Why?
| Pyrones | 1 | 2020 | 9 | 0.040 |
Why?
| Ribonucleotides | 1 | 2020 | 26 | 0.040 |
Why?
| Adenosine Triphosphate | 1 | 2022 | 474 | 0.040 |
Why?
| Biphenyl Compounds | 1 | 2020 | 55 | 0.040 |
Why?
| Mice, Knockout | 2 | 2017 | 2770 | 0.040 |
Why?
| Thiophenes | 1 | 2020 | 118 | 0.040 |
Why?
| Vasoconstrictor Agents | 1 | 2020 | 130 | 0.040 |
Why?
| Acetylcholine | 1 | 2020 | 185 | 0.040 |
Why?
| Vasodilator Agents | 1 | 2020 | 325 | 0.040 |
Why?
| Glucose | 1 | 2023 | 976 | 0.040 |
Why?
| Ultrasonography | 2 | 2014 | 727 | 0.040 |
Why?
| Evoked Potentials, Motor | 1 | 2017 | 41 | 0.040 |
Why?
| Renin | 1 | 2017 | 32 | 0.040 |
Why?
| Arginine Vasopressin | 1 | 2017 | 42 | 0.040 |
Why?
| Genotype | 2 | 2014 | 1834 | 0.040 |
Why?
| Aldosterone | 1 | 2017 | 43 | 0.040 |
Why?
| Recruitment, Neurophysiological | 1 | 2017 | 47 | 0.040 |
Why?
| Genome-Wide Association Study | 2 | 2017 | 1334 | 0.040 |
Why?
| Osmolar Concentration | 1 | 2017 | 166 | 0.030 |
Why?
| Ferritins | 1 | 2017 | 58 | 0.030 |
Why?
| Bisphosphoglycerate Mutase | 1 | 2016 | 7 | 0.030 |
Why?
| Ubiquitination | 1 | 2017 | 96 | 0.030 |
Why?
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 14 | 0.030 |
Why?
| Pentose Phosphate Pathway | 1 | 2016 | 49 | 0.030 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 41 | 0.030 |
Why?
| Sulfur | 1 | 2016 | 50 | 0.030 |
Why?
| Posture | 1 | 2017 | 174 | 0.030 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 134 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2016 | 291 | 0.030 |
Why?
| Purines | 1 | 2016 | 170 | 0.030 |
Why?
| Gene-Environment Interaction | 1 | 2017 | 185 | 0.030 |
Why?
| Arginine | 1 | 2016 | 254 | 0.030 |
Why?
| Diastole | 1 | 2015 | 151 | 0.030 |
Why?
| Vagus Nerve | 1 | 2015 | 85 | 0.030 |
Why?
| Glutathione | 1 | 2016 | 333 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2018 | 1504 | 0.030 |
Why?
| Enzyme Activation | 1 | 2016 | 811 | 0.030 |
Why?
| Receptor, Endothelin B | 1 | 2014 | 55 | 0.030 |
Why?
| Action Potentials | 1 | 2017 | 463 | 0.030 |
Why?
| Receptors, Endothelin | 1 | 2014 | 50 | 0.030 |
Why?
| Ultrasonography, Doppler, Transcranial | 1 | 2013 | 40 | 0.030 |
Why?
| Protein Processing, Post-Translational | 1 | 2016 | 448 | 0.030 |
Why?
| Evaluation Studies as Topic | 2 | 1991 | 175 | 0.030 |
Why?
| Infant | 2 | 2020 | 8994 | 0.030 |
Why?
| Body Weights and Measures | 1 | 2013 | 34 | 0.030 |
Why?
| Radial Artery | 1 | 2013 | 68 | 0.030 |
Why?
| Metabolome | 1 | 2016 | 316 | 0.030 |
Why?
| Aging | 1 | 2023 | 1767 | 0.030 |
Why?
| Acute Lung Injury | 1 | 2016 | 278 | 0.030 |
Why?
| Gonadal Steroid Hormones | 1 | 2014 | 134 | 0.030 |
Why?
| Brain | 1 | 2024 | 2592 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2014 | 356 | 0.020 |
Why?
| Exercise | 1 | 2023 | 1923 | 0.020 |
Why?
| Gene Regulatory Networks | 1 | 2014 | 278 | 0.020 |
Why?
| Cardiovascular Diseases | 1 | 2024 | 2013 | 0.020 |
Why?
| Obstetric Labor, Premature | 1 | 1992 | 35 | 0.020 |
Why?
| Linear Models | 1 | 2014 | 817 | 0.020 |
Why?
| Prevalence | 1 | 2018 | 2540 | 0.020 |
Why?
| Aged | 2 | 2023 | 22035 | 0.020 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2014 | 379 | 0.020 |
Why?
| Child | 1 | 2011 | 20824 | 0.020 |
Why?
| Pregnancy, High-Risk | 1 | 1991 | 12 | 0.020 |
Why?
| Laser-Doppler Flowmetry | 1 | 2011 | 34 | 0.020 |
Why?
| Live Birth | 1 | 2011 | 55 | 0.020 |
Why?
| Exercise Test | 1 | 2014 | 619 | 0.020 |
Why?
| Globins | 1 | 2010 | 21 | 0.020 |
Why?
| Procollagen-Proline Dioxygenase | 1 | 2010 | 27 | 0.020 |
Why?
| Iliac Artery | 1 | 2011 | 54 | 0.020 |
Why?
| Stillbirth | 1 | 2011 | 59 | 0.020 |
Why?
| Pregnancy Proteins | 1 | 2010 | 37 | 0.020 |
Why?
| Renin-Angiotensin System | 1 | 2010 | 80 | 0.020 |
Why?
| Interleukin-4 | 1 | 2010 | 214 | 0.020 |
Why?
| DNA Copy Number Variations | 1 | 2010 | 172 | 0.020 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 252 | 0.020 |
Why?
| Prenatal Care | 1 | 1992 | 272 | 0.020 |
Why?
| Pregnant Women | 1 | 1990 | 126 | 0.020 |
Why?
| Anticonvulsants | 1 | 2011 | 199 | 0.020 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 271 | 0.020 |
Why?
| Cross-Over Studies | 1 | 2011 | 513 | 0.020 |
Why?
| Intestinal Neoplasms | 1 | 1968 | 28 | 0.020 |
Why?
| Interleukin-10 | 1 | 2010 | 299 | 0.020 |
Why?
| Analysis of Variance | 1 | 2011 | 1283 | 0.020 |
Why?
| Transcription, Genetic | 1 | 2014 | 1408 | 0.020 |
Why?
| Radiotherapy | 1 | 1968 | 186 | 0.020 |
Why?
| Insurance, Health | 1 | 1990 | 269 | 0.020 |
Why?
| Models, Biological | 1 | 2015 | 1702 | 0.020 |
Why?
| Heart Rate, Fetal | 1 | 2007 | 20 | 0.020 |
Why?
| Lymphoma | 1 | 1968 | 190 | 0.020 |
Why?
| Infant, Premature | 1 | 1992 | 540 | 0.020 |
Why?
| Premature Birth | 1 | 2011 | 313 | 0.020 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 1968 | 113 | 0.020 |
Why?
| Middle Aged | 2 | 2019 | 30977 | 0.020 |
Why?
| Biometry | 1 | 2007 | 67 | 0.020 |
Why?
| Respiratory Mechanics | 1 | 2007 | 65 | 0.020 |
Why?
| Carcinoma | 1 | 1968 | 214 | 0.020 |
Why?
| Phylogeny | 1 | 2010 | 843 | 0.020 |
Why?
| Interleukin-6 | 1 | 2010 | 715 | 0.020 |
Why?
| Cognition | 1 | 2014 | 1093 | 0.020 |
Why?
| Patient Selection | 1 | 1990 | 671 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 1991 | 1840 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2017 | 7050 | 0.020 |
Why?
| Uterine Cervical Neoplasms | 1 | 1968 | 233 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2013 | 2767 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2010 | 1204 | 0.020 |
Why?
| Heart Failure | 1 | 2017 | 2142 | 0.010 |
Why?
| Patient Acceptance of Health Care | 1 | 1990 | 764 | 0.010 |
Why?
| Lower Extremity | 1 | 2007 | 404 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2010 | 2270 | 0.010 |
Why?
| France | 2 | 1992 | 30 | 0.010 |
Why?
| Risk Assessment | 1 | 2010 | 3286 | 0.010 |
Why?
| Educational Status | 2 | 1992 | 458 | 0.010 |
Why?
| Treatment Outcome | 1 | 2011 | 10239 | 0.010 |
Why?
| Hospitals, Maternity | 1 | 1992 | 4 | 0.010 |
Why?
| Fathers | 1 | 1992 | 47 | 0.010 |
Why?
| Marriage | 1 | 1992 | 111 | 0.010 |
Why?
| Occupations | 1 | 1990 | 42 | 0.010 |
Why?
| Social Values | 1 | 1990 | 35 | 0.010 |
Why?
| Resource Allocation | 1 | 1990 | 39 | 0.010 |
Why?
| Chromosome Disorders | 1 | 1990 | 39 | 0.010 |
Why?
| Personal Autonomy | 1 | 1990 | 48 | 0.010 |
Why?
| Religion | 1 | 1990 | 69 | 0.010 |
Why?
| Chromosome Aberrations | 1 | 1990 | 148 | 0.010 |
Why?
| Culture | 1 | 1990 | 125 | 0.010 |
Why?
| Estriol | 1 | 1968 | 7 | 0.000 |
Why?
| Pregnancy Trimester, Second | 1 | 1989 | 73 | 0.000 |
Why?
| Chorionic Gonadotropin | 1 | 1968 | 80 | 0.000 |
Why?
| Social Class | 1 | 1990 | 256 | 0.000 |
Why?
| Ileum | 1 | 1968 | 113 | 0.000 |
Why?
| Risk | 1 | 1990 | 866 | 0.000 |
Why?
| Smoking | 1 | 1992 | 1501 | 0.000 |
Why?
|
|
Julian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|